Cargando…
Third COVID-19 vaccine dose boosts neutralizing antibodies in poor responders
BACKGROUND: While evaluating COVID-19 vaccine responses using a rapid neutralizing antibody (NAb) test, we observed that 25% of mRNA vaccine recipients did not neutralize >50%. We termed this group “vaccine poor responders” (VPRs). The objective of this study was to determine if individuals who n...
Autores principales: | Lake, Douglas F., Roeder, Alexa J., Gonzalez-Moa, Maria J., Koehler, Megan, Kaleta, Erin, Jasbi, Paniz, Vanderhoof, John, McKechnie, Davis, Forman, Jack, Edwards, Baylee A., Seit-Nebi, Alim, Svarovsky, Sergei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273613/ https://www.ncbi.nlm.nih.gov/pubmed/35832309 http://dx.doi.org/10.1038/s43856-022-00151-2 |
Ejemplares similares
-
Longitudinal Comparison of Neutralizing Antibody Responses to COVID-19 mRNA Vaccines after Second and Third Doses
por: Roeder, Alexa J., et al.
Publicado: (2022) -
Letter to the editor RE: Fulford et al., 2021 ‘A point-of-care lateral flow assay for neutralizing antibodies against SARS-CoV-2’
por: Lake, Douglas F., et al.
Publicado: (2022) -
Development of a rapid point-of-care test that measures neutralizing antibodies to SARS-CoV-2
por: Lake, Douglas F., et al.
Publicado: (2021) -
Invariant amino acids essential for decoding function of polypeptide release factor eRF1
por: Kolosov, Petr, et al.
Publicado: (2005) -
Effect of in-vitro heat stress challenge on the function of blood mononuclear cells from dairy cattle ranked as high, average and low immune responders
por: Cartwright, Shannon L., et al.
Publicado: (2021)